The company continued to add new customers in the quarter, with 90 percent of its U.S. Waterlase sales from new buyers.
Biolase is anticipating its fourth-quarter revenue to be more than $13 million and its total 2022 revenue to rise at least 20 percent compared to 2021, the release said.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
